Lupin Ltd. | LUPIN | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Net Income
Net Income
35,431
5,468
15,172
8,768
16,765
Cash flow Operating Act...
Cash flow Operating Activities
41,14817,51216,66014,68818,218
Investments in PPE
Investments in PPE
-26,368-15,534-9,854-6,731-6,776
Cash flow Investing Act...
Net cash used for Investment Activities
-25,287-14,073-32,82511,070-12,396
Dividend Paid
Dividend Paid
4,0664,0732,7132,7302,723
Cash flow Financing Act...
Net cash provided by Financing Activities
4,332-14,9217,441-8,906-18,853
Cash at beginning of period
Cash at beginning of period
7,80227,99514,1645,44122,293
Cash at end of period
Cash at end of period
27,99516,5135,44122,2939,262
Free Cash Flow
Free Cash Flow
14,780
1,978
6,806
7,957
11,441